George Uhl currently works as Chief, Molecular Founding Editor of Addiction reviews; Adjunct Professor of Neurology, Johns Hopkins School of Medicine, Baltimore, Md, USA; Adjunct Professor of Neuroscience, Johns Hopkins School of Medicine; Adjunct Professor of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md, USA. Dr. Uhl is a board certified neurologist who received both M.D. and Ph.D. degrees in pharmacology at Johns Hopkins and postgraduate clinical training at Stanford and Johns Hopkins hospitals. He has served on the faculties of Johns Hopkins and/or Harvard Medical Schools since 1985, with support from the NIH and Howard Hughes Medical Institute intramural programs, and numerous grants. He is the author of more than 400 original manuscripts and reviews, Founding Editor of Addiction reviews, and recipient of numerous awards. He has been awarded patents for his elucidation of the genes for the dopamine transporter, a primary target for cocaine and Parkinsonism-inducing toxins, and the mu opiate receptor, the major opiate receptor for addiction and analgesia. His recent work focuses on the molecular neurobiology and genetics of addiction and related phenotypes in humans and mouse models.
Biography Updated on 2 November 2012